Lv21
120 积分 2024-02-22 加入
Molecular Residual Disease in Breast Cancer: Detection and Therapeutic Interception
7小时前
待确认
Prognostic value of ctDNA detection in patients with early breast cancer undergoing neoadjuvant therapy: A systematic review and meta-analysis
8小时前
已完结
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
19天前
已完结
Minimal residue disease detection in early-stage breast cancer: a review
19天前
已完结
Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
21天前
已完结
Dynamic ctDNA informs whole-course postoperative precise management of NSCLC (LUNGCA study)
1个月前
已完结
MRD-negativity after frontline DLBCL therapy: pooled analysis of 6 clinical trials
1个月前
已完结
Circulating Tumor DNA as Measurable Residual Disease in Aggressive B-Cell Lymphoma
1个月前
已完结
MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II–III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study
4个月前
已完结
Evaluation of molecular residual disease in operable non-small cell lung cancer with gene fusions, MET exon skipping or de novo MET amplification
6个月前
已完结
皖公网安备34019202002308
